Side effects and watch-outs
- Limited human safety data
- Potential liver stress at high doses — LFTs recommended
- Nausea
- Headache
- Theoretical interactions with other NAD+ compounds
- Regular bloodwork advised
Peptide / Metabolic
5-Amino-1MQ
NNMT (Nicotinamide N-Methyltransferase) inhibitor. Increases NAD+ precursors, reduces fat cell differentiation, improves metabolic health. Novel mechanism with limited human data.
Educational reference only. This page does not diagnose, prescribe, or replace care from a licensed professional. Laws, availability, and clinical appropriateness vary by location.